Regenerative Medicine – Thematic Research
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Regenerative Medicine is a burgeoning field in healthcare that holds the potential to fully cure patients of diseases, eliminate cancer, and fully repair and replace old and damaged tissue. There are three main branches of Regenerative Medicine: Gene Therapy, Cell Therapy, and Tissue Repair. Gene Therapies involve the replacement of a missing or defective gene in order to restore healthy function to a patient’s cells and tissues. Cell Therapies involve the use of cellular agents, either a patient’s own cells, or donor cells, in order to restore patient cellular and tissue balance. Tissue Repair Therapies involve the replacement and repair of damaged or diseased tissue in order to restore tissues to full and healthy function.
Scope
This is a single theme report providing in-house analyst expertise on regenerative medicine.
Components of the report include:
Key Players — identify some of the leading companies in regenerative medicine, split into key industry layers.
Trends — identify key trends expected to occur in the regenerative medicine industry over the next 12 to 24 months.
Industry Analysis — identify the impact of regenerative medicine across major markets.
Value Chain – identify the various business segments and markets related to the use of regenerative medicine in the medical device industry.
Key Highlights
The report primarily focuses on regenerative medicine therapies that act as medical devices and are not strictly drug-related.
Reasons to Buy
Develop and design your corporate strategies through an in-house expert analysis of regenerative medicine and the impact on the medical device industry.
Develop business strategies by understanding the primary ways in which regenerative medicine is changing the delivery of healthcare.
Stay up to date on the industry’s major players in regenerative medicine and where they sit in the value chain.
Identify emerging industry trends in regenerative medicine within the medical device sector to gain a competitive advantage.
Astellas Pharma
Athersys
Bayer
BioCardia
CartiHeal
DiscGenics
Fresenius
Gilead
J&J (DePuy)
Medtronic
Novartis
SanBio
Sangamo Therapeutics
Sernova
Smith & Nephew
Stryker
Vericel
ViaCyte
W.L. Gore
Table of Contents
Frequently asked questions
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.